Literature DB >> 23580073

What is riskier for the patient with an asymptomatic large hepatic hemangioma: observation or the surgeon?

Michael D'Angelica1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23580073     DOI： 10.1007/s00268-013-2042-5

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  5 in total

Review 1.  Benign liver neoplasms.

Authors:  Koenraad J Mortele; Pablo R Ros
Journal:  Clin Liver Dis       Date:  2002-02       Impact factor: 6.126

2.  Management of giant hemangioma of the liver: resection versus observation.

Authors:  Thomas Schnelldorfer; Adam L Ware; Rory Smoot; Cathy D Schleck; William S Harmsen; David M Nagorney
Journal:  J Am Coll Surg       Date:  2010-10-25       Impact factor: 6.113

3.  Management of hepatic hemangiomas: a 14-year experience.

Authors:  Paulo Herman; Marcelo L V Costa; Marcel Autran Cesar Machado; Vincenzo Pugliese; Luis Augusto Carneiro D'Albuquerque; Marcel Cerqueira César Machado; Joaquim Jose Gama-Rodrigues; William Abrão Saad
Journal:  J Gastrointest Surg       Date:  2005 Jul-Aug       Impact factor: 3.452

4.  Management of hemangioma of the liver: surgical therapy or observation?

Authors:  Süleyman Yedibela; Sedat Alibek; Volker Müller; Unal Aydin; Melanie Langheinrich; Clemens Lohmüller; Werner Hohenberger; Aristotelis Perrakis
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

5.  Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma.

Authors:  Sam S Yoon; Caleb K Charny; Yuman Fong; William R Jarnagin; Lawrence H Schwartz; Leslie H Blumgart; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2003-09       Impact factor: 6.113
  5 in total
  1 in total

1.  Surgical indication and strategy for liver hemangioma in the caudate lobe: a multi-institutional retrospective analysis with 137 patients.

Authors:  Wei Long Cai; Xiao Ming Ma; Xu Heng Sun; Tai Ren; Cong Yun Huang; Yong Sheng Li; Xu An Wang; Ying Bin Liu; Shu You Peng
Journal:  World J Surg Oncol       Date:  2020-06-10       Impact factor: 2.754
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.